Clinical characteristics of colorectal polyps in patients with non-alcoholic fatty liver disease in high altitude areas

Table 7 Univariable analyses of risk factors for adenomatous polyps occurrence in patients in Qinghai region

	OR	95%CI	P value
Sex	1.371	0.956-1.968	0.087
Age	0.993	0.978-1.009	0.416
Drinking history	1.039	0.712-1.516	0.844
Smoking history	0.728	0.510-1.039	0.080
Hypertension disease	0.655	0.455-0.944	0.023
Diabetes	0.722	0.464-1.123	0.148
Coronary heart disease	1.505	0.564-4.017	0.414
BMI	0.963	0.914-1.015	0.164
ALT	1.002	0.997-1.008	0.449
AST	1.002	0.993-1.011	0.673
GGT	1.000	0.997-1.003	0.860
ALP	1.001	0.994-1.008	0.755
ALB	0.992	0.957-1.028	0.648
TBIL	0.991	0.975-1.008	0.284
DBIL	0.983	0.948-1.019	0.355
IBIL	0.984	0.960-1.008	0.188
GLU	1.014	0.938-1.096	0.725
TG	1.048	0.928-1.183	0.452
TC	1.013	0.957-1.073	0.657
TBA	0.997	0.959-1.036	0.880
BUN	0.975	0.880-1.079	0.621
CRE	1.004	0.994-1.014	0.465
UA	1.001	0.999-1.002	0.528
HDL	0.816	0.462-1.441	0.484
LDL	1.100	0.857-1.411	0.454
WBC	1.093	1.017-1.174	0.015
RBC	0.880	0.686-1.128	0.313
HGB	0.997	0.989-1.005	0.479
PLT	1.000	0.997-1.003	0.980
PT	0.988	0.942-1.036	0.618
AFP	0.974	0.844-1.124	0.716
CA19-9	1.002	0.977-1.007	0.392
CEA	1.054	0.988-1.126	0.112

BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Γ-glutamyl transpeptidase; ALP: Alkaline phosphatase; ALB: Albumin; TBIL: Total bilirubin; DBIL: Direct bilirubin; IBIL: Indirect bilirubin; GLU: Glucose; TG: Triglycerides; TC: Total cholesterol; TBA: Total bile acids; BUN: Blood urea nitrogen; CRE: Creatinine; UA: Uric acid; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; WBC: White blood cell count; RBC: Red blood cell count; HGB: Hemoglobin; PLT: Platelet count; PT: Prothrombin time; AFP: Alpha-fetoprotein; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen.